These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30345303)

  • 1. Identification of Candidate Biomarkers in Malignant Ascites from Patients with Hepatocellular Carcinoma by iTRAQ-Based Quantitative Proteomic Analysis.
    Zhang J; Liang R; Wei J; Ye J; He Q; ChunlingYuan ; Ye J; Li Y; Liu Z; Lin Y
    Biomed Res Int; 2018; 2018():5484976. PubMed ID: 30345303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolome Profiling of Malignant Ascites Identifies Candidate Metabolic Biomarkers of Hepatocellular Carcinoma.
    Wang W; Wu Y; Zhang Q; Cui P
    Curr Med Chem; 2024; 31(13):1769-1780. PubMed ID: 38666505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative proteomic analysis of human malignant ascitic fluids for the development of gastric cancer biomarkers.
    Jin J; Son M; Kim H; Kim H; Kong SH; Kim HK; Kim Y; Han D
    Clin Biochem; 2018 Jun; 56():55-61. PubMed ID: 29654727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reveal the molecular signatures of hepatocellular carcinoma with different sizes by iTRAQ based quantitative proteomics.
    Wang Y; Liu H; Liang D; Huang Y; Zeng Y; Xing X; Xia J; Lin M; Han X; Liao N; Liu X; Liu J
    J Proteomics; 2017 Jan; 150():230-241. PubMed ID: 27693406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PD-L1
    Sun X; Gui Y; Yang T; Chen L; Zhang Y; Yan L; Chen W; Wang B
    Cancer Immunol Immunother; 2024 Oct; 73(12):254. PubMed ID: 39358478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative Proteomics Analysis of Tissue Interstitial Fluid for Identification of Novel Serum Candidate Diagnostic Marker for Hepatocellular Carcinoma.
    Sun W; Xing B; Guo L; Liu Z; Mu J; Sun L; Wei H; Zhao X; Qian X; Jiang Y; He F
    Sci Rep; 2016 May; 6():26499. PubMed ID: 27216119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ascitic Calprotectin as an early predictor of hepatocellular carcinoma in patients with cirrhotic ascites.
    Hanafy AS; Mohamed MS; Alnagar AA
    J Cancer Res Clin Oncol; 2020 Dec; 146(12):3207-3214. PubMed ID: 32851478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Protein Expression Changes in Hepatocellular Carcinoma through iTRAQ.
    Zhang Y; Ying X; Zhao Q; Ma J; Zhang D; He C; Han S
    Dis Markers; 2020; 2020():2632716. PubMed ID: 32076459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global proteomic profiling in multistep hepatocarcinogenesis and identification of PARP1 as a novel molecular marker in hepatocellular carcinoma.
    Xu X; Liu Z; Wang J; Xie H; Li J; Cao J; Zhou L; Zheng S
    Oncotarget; 2016 Mar; 7(12):13730-41. PubMed ID: 26883192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-219-5p Promotes Tumor Growth and Metastasis of Hepatocellular Carcinoma by Regulating Cadherin 1.
    Yang J; Sheng YY; Wei JW; Gao XM; Zhu Y; Jia HL; Dong QZ; Qin LX
    Biomed Res Int; 2018; 2018():4793971. PubMed ID: 29862272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ascitic fluid analysis in hepatocellular carcinoma.
    Colli A; Cocciolo M; Riva C; Marcassoli L; Pirola M; Di Gregorio P; Buccino G
    Cancer; 1993 Aug; 72(3):677-82. PubMed ID: 8392901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulated and downregulated proteins in hepatocellular carcinoma: a systematic review of proteomic profiling studies.
    Liu Z; Ma Y; Yang J; Qin H
    OMICS; 2011; 15(1-2):61-71. PubMed ID: 20726783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RRAD inhibits aerobic glycolysis, invasion, and migration and is associated with poor prognosis in hepatocellular carcinoma.
    Shang R; Wang J; Sun W; Dai B; Ruan B; Zhang Z; Yang X; Gao Y; Qu S; Lv X; Tao K; Wang L; Dou K; Wang D
    Tumour Biol; 2016 Apr; 37(4):5097-105. PubMed ID: 26546438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic profiling reveals the prognostic value of adenomatous polyposis coli-end-binding protein 1 in hepatocellular carcinoma.
    Orimo T; Ojima H; Hiraoka N; Saito S; Kosuge T; Kakisaka T; Yokoo H; Nakanishi K; Kamiyama T; Todo S; Hirohashi S; Kondo T
    Hepatology; 2008 Dec; 48(6):1851-63. PubMed ID: 18937283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Kindlin-1 in human hepatocellular carcinoma and its prognostic significance.
    Ma HX; Shu QH; Pan JJ; Liu D; Xu GL; Li JS; Ma JL; Jia WD; Yv JH; Ge YS
    Tumour Biol; 2015 Jun; 36(6):4235-41. PubMed ID: 25592379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effects of Euphorbia Pekinensis and Glycyrrhiza glabra on Hepatocellular Carcinoma Ascites Partially Via Regulating the Frk-Arhgdib-Inpp5d-Avpr2-Aqp4 Signal Axis.
    Zhang Y; Yan C; Li Y; Mao X; Tao W; Tang Y; Lin Y; Guo Q; Duan J; Lin N
    Sci Rep; 2017 Feb; 7():41925. PubMed ID: 28165501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic Characterization of Annexin l (ANX1) and Heat Shock Protein 27 (HSP27) as Biomarkers for Invasive Hepatocellular Carcinoma Cells.
    Wang RC; Huang CY; Pan TL; Chen WY; Ho CT; Liu TZ; Chang YJ
    PLoS One; 2015; 10(10):e0139232. PubMed ID: 26431426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of SAMSN1 Expression is Associated with the Malignant Phenotype of Hepatocellular Carcinoma.
    Sueoka S; Kanda M; Sugimoto H; Shimizu D; Nomoto S; Oya H; Takami H; Ezaka K; Hashimoto R; Tanaka Y; Okamura Y; Yamada S; Fujii T; Nakayama G; Koike M; Fujiwara M; Kodera Y
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1453-60. PubMed ID: 25805236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic identification of the macrophage-capping protein as a protein contributing to the malignant features of hepatocellular carcinoma.
    Kimura K; Ojima H; Kubota D; Sakumoto M; Nakamura Y; Tomonaga T; Kosuge T; Kondo T
    J Proteomics; 2013 Jan; 78():362-73. PubMed ID: 23085225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ESM1 as a Marker of Macrotrabecular-Massive Hepatocellular Carcinoma.
    Calderaro J; Meunier L; Nguyen CT; Boubaya M; Caruso S; Luciani A; Amaddeo G; Regnault H; Nault JC; Cohen J; Oberti F; Michalak S; Bouattour M; Vilgrain V; Pageaux GP; Ramos J; Barget N; Guiu B; Paradis V; Aubé C; Laurent A; Pawlotsky JM; Ganne-Carrié N; Zucman-Rossi J; Seror O; Ziol M
    Clin Cancer Res; 2019 Oct; 25(19):5859-5865. PubMed ID: 31358545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.